Functional alterations in endothelial NO, PGI2 and EDHF pathways in aorta in ApoE/LDLR-/- mice

Prostaglandins and Other Lipid Mediators

Volumn 98, Issue 3-4, 2012, Pages 107-115

  Csányi, Gábor ^a,e   Gajda, Mariusz ^a   Franczyk Zarow, Magdalena ^b   Kostogrys, Renata ^b   Gwoźdź, Pawel ^a   Mateuszuk, Lukasz ^c   Sternak, Magdalena ^a,c   Wojcik, Luiza ^d   Zalewska, Teresa ^d   Walski, Michal ^d   Chlopicki, Stefan ^a,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; EDHF; Endothelial dysfunction; Gene targeted mice; Nitric oxide; Prostacyclin

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN E; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; MATRIX METALLOPROTEINASE; PROSTACYCLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRON MICROSCOPE; ENZYME ACTIVITY; LIPID STORAGE; MOUSE; NONHUMAN; THORACIC AORTA;

ANIMALS; AORTA; APOLIPOPROTEINS E; BIOLOGICAL FACTORS; CYCLOOXYGENASE 2; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HYDROGEN PEROXIDE; HYPERCHOLESTEROLEMIA; LIPIDS; MICE; MICE, INBRED C57BL; NITRIC OXIDE; RECEPTORS, LDL; UP-REGULATION; VASODILATION;

EID: 84864495175     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2012.02.002     Document Type: Article

References (57)

1. P.O. Bonetti, L.O. Lerman, and A. Lerman Endothelial dysfunction: a marker of atherosclerotic risk Arterioscler Thromb Vasc Biol 23 2003 168 175
2. G. Csanyi, I. Lepran, T. Flesch, G. Telegdy, G. Szabo, and Z. Mezei Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats Pharmacol Rep 59 2007 447 455
3. N. Gokce, J.F. Keaney Jr., and L.M. Hunter Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease J Am Coll Cardiol 41 2003 1769 1775
4. S. Patel, and D.S. Celermajer Assessment of vascular disease using arterial flow mediated dilatation Pharmacol Rep 58 Suppl. 2006 3 7
5. N. Weckler, D. Leitzbach, L. Kalinowski, T. Malinski, A.E. Busch, and W. Linz Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits J Renin Angiotensin Aldosterone Syst 4 2003 191 196
6. J.R. Turk, K.K. Henderson, G.D. Vanvickle, J. Watkins, and M.H. Laughlin Arterial endothelial function in a porcine model of early stage atherosclerotic vascular disease Int J Exp Pathol 86 2005 335 345
7. T. Adachi, R.M. Weisbrod, and D.R. Pimentel S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide Nat Med 10 2004 1200 1207
8. S. Bonthu, D.D. Heistad, D.A. Chappell, K.G. Lamping, and F.M. Faraci Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice Arterioscler Thromb Vasc Biol 17 1997 2333 2340
9. N. Villeneuve, A. Fortuno, and M. Sauvage Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein-E-deficient mice J Vasc Res 40 2003 87 96
10. H.M. Crauwels, C.E. Van Hove, P. Holvoet, A.G. Herman, and H. Bult Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI Cardiovasc Res 59 2003 189 199
11. J.B. Laursen, M. Somers, and S. Kurz Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin Circulation 103 2001 1282 1288
12. P.W. Shaul Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis J Physiol 547 2003 21 33
13. S.M. Bode-Boger, F. Scalera, and L.J. Ignarro The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio Pharmacol Ther 114 2007 295 306
14. T.J. Verbeuren, F.H. Jordaens, C.E. Van Hove, A.E. Van Hoydonck, and Herman A.G. Release vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta Eur J Pharmacol 191 1990 173 184
15. P.A. Jorge, M.R. Osaki, E. de Almeida, L. Credidio Neto, and K. Metze Effects of vitamin E on endothelium-dependent coronary flow in hypercholesterolemic dogs Atherosclerosis 126 1996 43 51
16. C.A. Hamilton, C.A. Howie, E. Jardine, and J.L. Reid Endothelium dependent and independent relaxation of aortic rings from Watanabe heritable hyperlipidemic rabbits after exposure to free radical generating system Free Radic Res 28 1998 251 257
17. A.H. Singer, P.S. Tsao, B.Y. Wang, D.A. Bloch, and J.P. Cooke Discordant effects of dietary l-arginine on vascular structure and reactivity in hypercholesterolemic rabbits J Cardiovasc Pharmacol 25 1995 710 716
18. L. Luksha, S. Agewall, and K. Kublickiene Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease Atherosclerosis 202 2009 330 344
19. H. Shimokawa, H. Yasutake, and K. Fujii The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation J Cardiovasc Pharmacol 28 1996 703 711
20. L. Urakami-Harasawa, H. Shimokawa, M. Nakashima, K. Egashira, and A. Takeshita Importance of endothelium-derived hyperpolarizing factor in human arteries J Clin Invest 100 1997 2793 2799
21. G. Csanyi, M. Bauer, and W. Dietl Functional alterations in NO, PGI2 and EDHF pathways in the aortic endothelium after myocardial infarction in rats Eur J Heart Fail 8 2006 769 776
22. P.L. Huang, Z. Huang, and H. Mashimo Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 1995 239 242
23. P.M. Vanhoutte Endothelial dysfunction: the first step toward coronary arteriosclerosis Circ J 73 2009 595 601
24. D.D. Smith, X. Tan, O. Tawfik, G. Milne, D.J. Stechschulte, and K.N. Dileepan Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production J Physiol Pharmacol 61 2010 309 316
25. J.L. Mehta, D. Lawson, P. Mehta, and T. Saldeen Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis Proc Natl Acad Sci U S A 85 1988 4511 4515
26. J. Jawien, G. Csanyi, and M. Gajda Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice Eur J Pharmacol 556 2007 129 135
27. -/-) Br J Nutr 99 2008 49 58
28. S. Rivera, C. Ogier, and J. Jourquin Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia Eur J Neurosci 15 2002 19 32
29. S. Chlopicki, M. Walski, and J.B. Bartus Ultrastructure of immediate microvascular lung injury induced by bacterial endotoxin in the isolated, no-deficient lung perfused with full blood J Physiol Pharmacol 56 Suppl. 4 2005 47 64
30. S. Ishibashi, J. Herz, N. Maeda, J.L. Goldstein, and M.S. Brown The two-receptor model of lipoprotein clearance: tests of the hypothesis in knockout mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins Proc Natl Acad Sci U S A 91 1994 4431 4435
31. O.A. Belton, A. Duffy, S. Toomey, and D.J. Fitzgerald Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis Circulation 108 2003 3017 3023
32. G.A. FitzGerald, B. Smith, A.K. Pedersen, and A.R. Brash Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation N Engl J Med 310 1984 1065 1068
33. T. Kobayashi, Y. Tahara, and M. Matsumoto Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice J Clin Invest 114 2004 784 794
34. T. Grosser, S. Fries, and G.A. FitzGerald Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities J Clin Invest 116 2006 4 15
35. B. Fisslthaler, R. Popp, and L. Kiss Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
36. S.L. Pfister, J.R. Falck, and W.B. Campbell Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta Am J Physiol 261 1991 H843 H852
37. M. Bachschmid, S. Schildknecht, and V. Ullrich Redox regulation of vascular prostanoid synthesis by the nitric oxide-superoxide system Biochem Biophys Res Commun 338 2005 536 542
38. J. Bauersachs, R. Popp, M. Hecker, E. Sauer, I. Fleming, and R. Busse Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor Circulation 94 1996 3341 3347
39. K. Node, Y. Huo, and X. Ruan Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 1999 1276 1279
40. T.J. Verbeuren, M.C. Coene, F.H. Jordaens, C.E. Van Hove, L.L. Zonnekeyn, and A.G. Herman Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits Circ Res 59 1986 496 504
41. K. Schmidt, P. Klatt, and B. Mayer Hypercholesterolemia is associated with a reduced response of smooth muscle guanylyl cyclase to nitrovasodilators Arterioscler Thromb 13 1993 1159 1163
42. R.I. Cohen, D. Wilson, and S.F. Liu Nitric oxide modifies the sarcoplasmic reticular calcium release channel in endotoxemia by both guanosine-3′,5′ (cyclic) phosphate-dependent and independent pathways Crit Care Med 34 2006 173 181
43. F. Jiang, Y. Guo, D. Salvemini, and G.J. Dusting Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice Brit J Pharmacol 139 2003 1127 1134
44. Y. Ohara, T.E. Peterson, and D.G. Harrison Hypercholesterolemia increases endothelial superoxide anion production J Clin Invest 91 1993 2546 2551
45. L.V. d'Uscio, T.A. Baker, and C.B. Mantilla Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 21 2001 1017 1022
46. N.J. Alp, M.A. McAteer, J. Khoo, R.P. Choudhury, and K.M. Channon Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice Arterioscler Thromb Vasc Biol 24 2004 445 450
47. S. Chlopicki, and R.J. Gryglewski Angiotensin converting enzyme (ACE) and hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium Pharmacol Rep 57 Suppl. 2005 86 96
48. M. Walski, S. Chlopicki, R. Celary-Walska, and M. Frontczak-Baniewicz Ultrastructural alterations of endothelium covering advanced atherosclerotic plaque in human carotid artery visualised by scanning electron microscope J Physiol Pharmacol 53 2002 713 723
49. G.K. Hansson, A.K. Robertson, and C. Soderberg-Naucler Inflammation and atherosclerosis Annu Rev Pathol 1 2006 297 329
50. A.C. Newby Metalloproteinases and vulnerable atherosclerotic plaques Trends Cardiovasc Med 17 2007 253 258
51. P. Libby The molecular mechanisms of the thrombotic complications of atherosclerosis J Intern Med 263 2008 517 527
52. T.J. Anderson, M.D. Gerhard, and I.T. Meredith Systemic nature of endothelial dysfunction in atherosclerosis Am J Cardiol 75 1995 71B 74B
53. R. Yang, L. Powell-Braxton, and A.K. Ogaoawara Hypertension and endothelial dysfunction in apolipoprotein E knockout mice Arterioscler Thromb Vasc Biol 19 1999 2762 2768
54. P.A. Stapleton, A.G. Goodwill, M.E. James, and J.C. Frisbee Altered mechanisms of endothelium-dependent dilation in skeletal muscle arterioles with genetic hypercholesterolemia Am J Physiol Regul Integr Comp Physiol 293 2007 R1110 R1119
55. S.E. Wolfle, and C. de Wit Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo J Vasc Res 42 2005 475 482
56. B.T. Larsen, W.B. Campbell, and D.D. Gutterman Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system Trends Pharmacol Sci 28 2007 32 38
57. S. Chlopicki, J. Swies, and A. Mogielnicki 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway Brit J Pharmacol 152 2007 230 239